Rocket Pharmaceuticals logo

Rocket Pharmaceuticals share price today

(RCKT)

Rocket Pharmaceuticals share price is $12.02 & ₹1,024.95 as on 27 Dec 2024, 2.30 'hrs' IST

$12.02

0.34

(2.91%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Rocket Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Rocket Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Rocket Pharmaceuticals. Get details on the Indian mutual funds that are investing in Rocket Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Rocket Pharmaceuticals's financials.

Rocket Pharmaceuticals share price movements

  • Today's Low: $11.38
    Today's High: $12.11

    Day's Volatility :6.03%

  • 52 Weeks Low: $11.15
    52 Weeks High: $32.53

    52 Weeks Volatility :65.72%

Rocket Pharmaceuticals Returns

PeriodRocket Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-36.73%
-9.0%
0.0%
6 Months
-45.75%
-4.6%
0.0%
1 Year
-62.2%
3.0%
0.0%
3 Years
-49.2%
0.0%
-21.1%

Rocket Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$11.68
Open
$11.56
Today's High
$12.11
Today's Low
$11.3792
Market Capitalization
$1.2B
Today's Volume
$700.2K
52 Week High
$32.525
52 Week Low
$11.15
Revenue TTM
$0.0
EBITDA
$-264.8M
Earnings Per Share (EPS)
$-2.73
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-59.27%

How to invest in Rocket Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Rocket Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rocket Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rocket Pharmaceuticals or RCKT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rocket Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rocket Pharmaceuticals shares which would translate to 0.071 fractional shares of Rocket Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rocket Pharmaceuticals, in just a few clicks!

Returns in Rocket Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rocket Pharmaceuticals investment value today

Current value as on today

₹41,225

Returns

₹58,775

(-58.78%)

Returns from Rocket Pharmaceuticals Stock

₹61,100 (-61.1%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Rocket Pharmaceuticals

164%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Rocket Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 27, 2024. 164% more investors are searching Rocket Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Rocket Pharmaceuticals

  • RTW INVESTMENTS, LLC

    19.40%

  • Wellington Management Company LLP

    12.33%

  • BlackRock Inc

    6.79%

  • Vanguard Group Inc

    6.07%

  • Westfield Capital Management Company, L.P.

    4.93%

  • Maverick Capital Ltd

    4.52%

Analyst Recommendation on Rocket Pharmaceuticals

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 21 Wall street analysts offering stock ratings for Rocket Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
19
19
19
Hold
2
1
1
Sell
0
0
0

Analyst Forecast on Rocket Pharmaceuticals

What analysts predicted

Upside of 268.28%

Current:

$12.02

Target:

$44.27

Insights on Rocket Pharmaceuticals

  • Price Movement

    In the last 3 months, RCKT stock has moved down by -33.6%
  • RCKT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 89.8%
  • RCKT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 76.5%

Rocket Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Rocket Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Rocket Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Rocket Pharmaceuticals Inc
-17.75%
-45.75%
-62.2%
-49.2%
-49.48%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.02%
-18.97%
11.91%
91.19%
Biontech Se
-3.72%
42.02%
7.95%
-52.72%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
0.1%
24.29%
44.19%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-12.92%
-0.27%
83.92%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Rocket Pharmaceuticals Inc
NA
NA
NA
-2.8
-0.59
-0.34
NA
3.62
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Rocket Pharmaceuticals Inc
Buy
$1.2B
-49.48%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Rocket Pharmaceuticals

rocket pharmaceuticals, ltd is a biotechnology company focused on seeking cures through molecular and gene therapy. we are developing first-in-class treatments for patients with rare and often devastating orphan diseases using a lentiviral-based gene therapy approach. we have developed rewarding partnerships with a number of leading international research institutions as well as with centers of manufacturing and cell processing expertise, while building an internal team to drive the research, development, clinical and regulatory programs. ultimately we aim to launch and globally commercialize innovative gene therapies in disease areas with high unmet need. for more information, please visit www.rocketpharma.com.
Organization
Rocket Pharmaceuticals
Employees
268
CEO
Dr. Gaurav D. Shah M.D.
Industry
Health Technology

Management People of Rocket Pharmaceuticals

NameTitle
Dr. Gaurav D. Shah M.D.
CEO & Director
Ms. Kinnari Patel M.B.A., Pharm.D.
Head of R&D, President & COO
Mr. Mayo Pujols
Chief Technical Officer
Mr. Jonathan Schwartz M.D.
Chief Medical & Gene Therapy Officer
Mr. Aaron Ondrey
Chief Financial Officer
Mr. Martin Louis Wilson J.D.
General Counsel, Chief Compliance Officer & Chief Corporate Officer
Kevin Giordano
Director of Corporate Communications
Ms. Isabel Carmona J.D.
Chief People Officer
Dr. Gayatri R. Rao J.D., M.D.
Senior VP of Clinical Safety & Chief Regulatory Officer
Mr. Raj Prabhakar M.B.A.
Chief Business Officer

Important FAQs about investing in Rocket Pharmaceuticals from India :

What is Rocket Pharmaceuticals share price today?

Rocket Pharmaceuticals share price today stands at $12.02, Open: $11.56 ; Previous Close: $11.68 ; High: $12.11 ; Low: $11.38 ; 52 Week High: $32.53 ; 52 Week Low: $11.15. The stock opens at $11.56, after a previous close of $11.68. The stock reached a daily high of $12.11 and a low of $11.38, with a 52-week high of $32.53 and a 52-week low of $11.15.

Can Indians buy Rocket Pharmaceuticals shares?

Yes, Indians can invest in the Rocket Pharmaceuticals (RCKT) from India.

With INDmoney, you can buy Rocket Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Rocket Pharmaceuticals at zero transaction cost.

How can I buy Rocket Pharmaceuticals shares from India?

It is very easy to buy Rocket Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rocket Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Rocket Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Rocket Pharmaceuticals stocks?

To start investing in Rocket Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Rocket Pharmaceuticals

Today’s highest price of Rocket Pharmaceuticals (RCKT) is $12.11.

Today’s lowest price of Rocket Pharmaceuticals (RCKT) is $11.38.

What is today's market capitalisation of Rocket Pharmaceuticals

Today's market capitalisation of Rocket Pharmaceuticals RCKT is 1.2B

What is the 52 Week High and Low Range of Rocket Pharmaceuticals

  • 52 Week High

    $32.53

  • 52 Week Low

    $11.15

What are the historical returns of Rocket Pharmaceuticals?

  • 1 Month Returns

    -17.75%

  • 3 Months Returns

    -45.75%

  • 1 Year Returns

    -62.2%

  • 5 Years Returns

    -49.48%

Who is the Chief Executive Officer (CEO) of Rocket Pharmaceuticals

Dr. Gaurav D. Shah M.D. is the current Chief Executive Officer (CEO) of Rocket Pharmaceuticals.